{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T22:31:30Z","timestamp":1766788290464},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1208\/s12248-017-0158-5","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T15:19:24Z","timestamp":1512659964000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Demonstration of Nucleoside Transporter Activity in the Nose-to-Brain Distribution of [18F]Fluorothymidine Using PET Imaging"],"prefix":"10.1208","volume":"20","author":[{"given":"Laura L. Boles","family":"Ponto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan A.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Mundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Sunderland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"issue":"4","key":"158_CR1","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"S Dhuria","year":"2010","unstructured":"Dhuria S, Hanson L, Frey W. Intranasal delivery to the central nervous system: mechanism and experimental considerations. J Pharm Sci. 2010;99(4):1654\u201373. \nhttps:\/\/doi.org\/10.1002\/jps.21924\n\n.","journal-title":"J Pharm Sci"},{"issue":"1","key":"158_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","volume":"11","author":"L Illum","year":"2000","unstructured":"Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 2000;11(1):1\u201318. \nhttps:\/\/doi.org\/10.1016\/S0928-0987(00)00087-7\n\n.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"158_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijpharm.2009.05.009","volume":"377","author":"T Shingaki","year":"2009","unstructured":"Shingaki T, Hidalgo IJ, Furubayashi T, Katsumi H, Sakane T, Yamamoto A, et al. The transnasal delivery of 5-fluorouracil to the rat brain is enhanced by acetazolamide (the inhibitor of the secretion of cerebrospinal fluid). Int J Pharm. 2009;377(1):85\u201391. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2009.05.009\n\n.","journal-title":"Int J Pharm"},{"issue":"3","key":"158_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/jcbfm.2014.215","volume":"35","author":"JJ Lochhead","year":"2015","unstructured":"Lochhead JJ, Wolak DJ, Pizzo ME, Thorne RG. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. J Cereb Blood Flow Metab. 2015;35(3):371\u201381. \nhttps:\/\/doi.org\/10.1038\/jcbfm.2014.215\n\n.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"158_CR5","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.4155\/fmc.14.77","volume":"6","author":"U Anand","year":"2014","unstructured":"Anand U, Parikh A, Ugwu MC, Agu RU. Drug transporters in the nasal epithelium: an overview of strategies in targeted drug delivery. Future Med Chem. 2014;6(12):1381\u201397. \nhttps:\/\/doi.org\/10.4155\/fmc.14.77\n\n.","journal-title":"Future Med Chem"},{"issue":"1","key":"158_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11095-004-9013-3","volume":"22","author":"CL Graff","year":"2005","unstructured":"Graff CL, Pollack GM. Functional evidence for P-glycoprotein at the nose-brain barrier. Pharm Res. 2005;22(1):86\u201393. \nhttps:\/\/doi.org\/10.1007\/s11095-004-9013-3\n\n.","journal-title":"Pharm Res"},{"issue":"7","key":"158_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s11095-005-5420-3","volume":"22","author":"KK Kandimalla","year":"2005","unstructured":"Kandimalla KK, Donovan MD. Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae. Pharm Res. 2005;22(7):1121\u20138. \nhttps:\/\/doi.org\/10.1007\/s11095-005-5420-3\n\n.","journal-title":"Pharm Res"},{"issue":"6","key":"158_CR8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1021\/mp070032u","volume":"4","author":"NV Chemuturi","year":"2007","unstructured":"Chemuturi NV, Donovan MD. Role of organic cation transporters in dopamine uptake across olfactory and nasal respiratory tissues. Mol Pharm. 2007;4(6):936\u201342. \nhttps:\/\/doi.org\/10.1021\/mp070032u\n\n.","journal-title":"Mol Pharm"},{"issue":"8","key":"158_CR9","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1021\/acs.molpharmaceut.5b00103","volume":"12","author":"M Al-Ghabeish","year":"2015","unstructured":"Al-Ghabeish M, Scheetz T, Assem M, Donovan MD. Microarray determination of the expression of drug transporters in humans and animal species used for the investigation of nasal absorption. Mol Pharm. 2015;12(8):2742\u201354. \nhttps:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00103\n\n.","journal-title":"Mol Pharm"},{"issue":"3","key":"158_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2133\/dmpk.DMPK-10-RG-108","volume":"26","author":"T Shingaki","year":"2011","unstructured":"Shingaki T, Hidalgo IJ, Furubayashi T, Sakane T, Katsumi H, Yamamoto A, et al. Nasal delivery of P-gp substrates to the brain through the nose-brain pathway. Drug Metabolism and Pharmacokinetics. 2011;26(3):248\u201355. \nhttps:\/\/doi.org\/10.2133\/dmpk.DMPK-10-RG-108\n\n.","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"158_CR11","unstructured":"George M. The role of organic cation transporters in the nasal uptake and brain distribution of organic cation substrates: University of Iowa; 2013. \nhttp:\/\/ir.uiowa.edu\/cgi\/viewcontent.cgi?article=5657&context=etd\n\n (use accessed 15 Sept 2017)."},{"issue":"8","key":"158_CR12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1248\/bpb.17.1135","volume":"17","author":"T Seki","year":"1994","unstructured":"Seki T, Sato N, Hasegawa T, Kawaguchi T, Juni K. Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats. Biol Pharm Bull. 1994;17(8):1135\u20137. \nhttps:\/\/doi.org\/10.1248\/bpb.17.1135\n\n.","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"158_CR13","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/jps.20334","volume":"94","author":"Z Yang","year":"2005","unstructured":"Yang Z, Huang Y, Gan G, Sawchuk RJ. Microdialysis evaluation of the brain distribution of stavudine following intranasal and intravenous administration to rats. J Pharm Sci. 2005;94(7):1577\u201388. \nhttps:\/\/doi.org\/10.1002\/jps.20334\n\n.","journal-title":"J Pharm Sci"},{"key":"158_CR14","unstructured":"Zidovudine [Internet]. Wishart Research Group. [cited June 25, 2017]. Available from: \nhttps:\/\/www.drugbank.ca\/drugs\/DB00495"},{"key":"158_CR15","unstructured":"Stavudine [Internet]. Wishart Research Group. [cited June 25, 2017]. Available from: \nhttps:\/\/www.drugbank.ca\/drugs\/DB0064\n\n."},{"issue":"12","key":"158_CR16","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1128\/AAC.33.12.2083","volume":"33","author":"R Koshida","year":"1989","unstructured":"Koshida R, Cox S, Harmenberg J, Gilljam G, Wahren B. Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1989;33(12):2083\u20138. \nhttps:\/\/doi.org\/10.1128\/AAC.33.12.2083\n\n.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"158_CR17","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/3337","volume":"4","author":"AF Shields","year":"1998","unstructured":"Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4(11):1334\u20136. \nhttps:\/\/doi.org\/10.1038\/3337\n\n.","journal-title":"Nat Med"},{"issue":"12","key":"158_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/01.rlu.0000246820.14892.d2","volume":"31","author":"TMD Saga","year":"2006","unstructured":"Saga TMD, Kawashima H, Araki N, Takahashi JA, Nakashima Y, Higashi T, et al. Evaluation of primary brain tumors with FLT-PET: usefulness and limitations. Clin Nucl Med. 2006;31(12):774\u201380. \nhttps:\/\/doi.org\/10.1097\/01.rlu.0000246820.14892.d2\n\n.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"158_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10014-013-0136-2","volume":"30","author":"A Shinomiya","year":"2013","unstructured":"Shinomiya A, Miyake K, Okada M, Nakamura T, Kawai N, Kushida Y, et al. 3\u2032-Deoxy-3\u2032-[18F]-fluorothymidine ([18F]-FLT) transport in newly diagnosed glioma: correlation with nucleoside transporter expression, vascularization, and blood\u2013brain barrier permeability. Brain Tumor Pathology. 2013;30(4):215\u201323. \nhttps:\/\/doi.org\/10.1007\/s10014-013-0136-2\n\n.","journal-title":"Brain Tumor Pathology"},{"issue":"2","key":"158_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","volume":"34","author":"JD Young","year":"2013","unstructured":"Young JD, Yao SYM, Baldwin JM, Cass CE, Baldwin SA. The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol Asp Med. 2013;34(2):529\u201347. \nhttps:\/\/doi.org\/10.1016\/j.mam.2012.05.007\n\n.","journal-title":"Mol Asp Med"},{"key":"158_CR21","volume-title":"Drug transporters in the nasal epithelia and their contributions in drug delivery: University of Iowa","author":"M Al-Ghabeish","year":"2013","unstructured":"Al-Ghabeish M. Drug transporters in the nasal epithelia and their contributions in drug delivery: University of Iowa; 2013. \nhttp:\/\/ir.uiowa.edu\/cgi\/viewcontent.cgi?article=5581&context=etd"},{"issue":"5","key":"158_CR22","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1124\/mol.108.048900","volume":"74","author":"RJ Paproski","year":"2008","unstructured":"Paproski RJ, Ng AML, Yao SYM, Graham K, Young JD, Cass CE. The role of human nucleoside transporters in uptake of 3\u2032-deoxy-3\u2032-fluorothymidine. Mol Pharmacol. 2008;74(5):1372\u201380. \nhttps:\/\/doi.org\/10.1124\/mol.108.048900\n\n.","journal-title":"Mol Pharmacol"},{"issue":"9","key":"158_CR23","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2967\/jnumed.110.076356","volume":"51","author":"RJ Paproski","year":"2010","unstructured":"Paproski RJ, Wuest M, Jans H-S, Graham K, Gati WP, McQuarrie S, et al. Biodistribution and uptake of 3\u2032-deoxy-3\u2032-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model. J Nucl Med. 2010;51(9):1447\u201355. \nhttps:\/\/doi.org\/10.2967\/jnumed.110.076356\n\n.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"158_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00003088-199936001-00004","volume":"36","author":"M Bergstrom","year":"1999","unstructured":"Bergstrom M, Cass LMR, Valind S, Westerberg G, Lundberg E-L, Gray S, et al. Deposition and disposition of [11C]zanamivir following administration as an intranasal spray. Clin Pharmacokinet. 1999;36(Suppl 1):33\u20139. \nhttps:\/\/doi.org\/10.2165\/00003088-199936001-00004\n\n.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"158_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/j.1468-2982.2005.00966.x","volume":"25","author":"R Yates","year":"2005","unstructured":"Yates R, S\u00f6rensen J, Bergstr\u00f6m M, Antoni G, Nairn K, Kemp K, et al. Distribution of intranasal 11C-zolmitriptan assessed by positron emission tomography. Cephalalgia. 2005;25(12):1103\u20139. \nhttps:\/\/doi.org\/10.1111\/j.1468-2982.2005.00966.x\n\n.","journal-title":"Cephalalgia"},{"key":"158_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejpb.2015.11.014","volume":"99","author":"T Shingaki","year":"2016","unstructured":"Shingaki T, Katayama Y, Nakaoka T, Irie S, Onoe K, Okauchi T, et al. Visualization of drug translocation in the nasal cavity and pharmacokinetic analysis on nasal drug absorption using positron emission tomography in the rat. Eur J Pharm Biopharm. 2016;99:45\u201353. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2015.11.014\n\n.","journal-title":"Eur J Pharm Biopharm"},{"key":"158_CR27","doi-asserted-by":"crossref","unstructured":"Ponto LLB, Walsh SA, Huang J, Mundt C, Thede-Reynolds K, Watkins GL, et al. Pharmacoimaging of blood-brain barrier permeable (FDG) and impermeable (FLT) substrates after intranasal (IN) administration. AAPS J. In review.","DOI":"10.1208\/s12248-017-0157-6"},{"issue":"4","key":"158_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s002800050667","volume":"40","author":"WP Gati","year":"1997","unstructured":"Gati WP, Paterson ARP. Measurement of nitrobenzylthioinosine in plasma and erythrocytes: a pharmacokinetic study in mice. Cancer Chemother Pharmacol. 1997;40(4):342\u20136. \nhttps:\/\/doi.org\/10.1007\/s002800050667\n\n.","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-017-0158-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0158-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0158-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T14:41:33Z","timestamp":1523889693000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-017-0158-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["158"],"URL":"https:\/\/doi.org\/10.1208\/s12248-017-0158-5","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]},"article-number":"16"}}